EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease

Anke Beermann iD, Ophélie Clottu, Marcus Reif, Ulrike Biegel, Lucia Unger iD, Christoph Koch iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Anke Beermann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Organic Agriculture (FiBL), Department of Livestock Sciences, Frick, Switzerland. Hauptthemen laut MEDLINE: Horse Diseases, Plant Extracts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Society of Cancer Research, Arlesheim, Switzerland, The Veterinary Association of the Canton of Neuchâtel, Neuchâtel, Switzerland, The Swiss Veterinary Association for Alternative and Complementary Medicine (camvet.ch), Bern, Switzerland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Equine sarcoids (ES) are the most common cutaneous tumors in equids. Systemic treatment options are sparse. Subcutaneous (SC) injections of Viscum album extract (VAE) demonstrate efficacy as a systemic treatment directed against ES. Objectives/Aim To critically assess the therapeutic efficacy of orally administered VAE. Animals Forty-five ES-affected, privately owned, 3–12 year-old horses.

Methods

A 3-armed randomized placebo-controlled, double-blinded study was conducted in a double-dummy design. Horses were subjected to oral administration and SC injections of either VAE or placebo (VAE oral/placebo SC, VAE SC/placebo oral, placebo oral/placebo SC) over a 7-month treatment period. Primary endpoint was the change of baseline of a composite index of ES number and ES area after 14 months. Second endpoint was the clinical response.

Results

No statistically significant difference in the composite endpoint between the 3 study arms was found. The primary endpoint showed 4 (27%) horses in the VAE oral group with complete ES regression, 3 (21%) in the VAE SC injection group, and 2 (13%) in the placebo group. The clinical response revealed complete or partial regression in 6 horses of the oral VAE group (40%), 4 of the SC injection group (29%), and 4 of the placebo group (25%). Direct comparison of oral VAE and placebo showed an odds ratio, stratified for prognosis of 2.16 (95%-CI: 0.45–10.42) and a P-value of 0.336. Conclusion and Clinical Importance Oral administration of VAE is well tolerated. No statistically significant difference in the effectiveness of systemic VAE versus placebo against ES was found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Horse DiseasesPlant ExtractsAnimalsHorsesAdministration, OralInjections, SubcutaneousDouble-Blind MethodFemaleMaleSkin NeoplasmsSarcoidosisViscum album

Stichwörter der Autor:innen

Viscum album extractequine sarcoidhorseimmunotherapymistletoerandomized trial

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • Research Institute of Organic Agriculture (FiBL), Department of Livestock Sciences, Frick, Switzerland.
  • Society of Clinical Research e.V, Berlin, Germany.
  • Department of Clinical Veterinary Medicine, Swiss Institute of Equine Medicine (ISME), University of Bern, Bern, Switzerland.

ORCID-Profile: Anke Beermann, Lucia Unger, Christoph Koch

Förderung

  • The Society of Cancer Research, Arlesheim, Switzerland
  • The Veterinary Association of the Canton of Neuchâtel, Neuchâtel, Switzerland
  • The Swiss Veterinary Association for Alternative and Complementary Medicine (camvet.ch), Bern, Switzerland
  • The Rudolf Steiner Fund for Scientific Research e.V., Nuremberg, Germany

Zitieren

APA

Beermann, A., Clottu, O., Reif, M., Biegel, U., Unger, L., & Koch, C. (2024). A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17052

Vancouver

Beermann A, Clottu O, Reif M, Biegel U, Unger L, Koch C. A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17052

BibTeX
@article{Beermann2024,
  author = {Beermann, Anke and Clottu, Ophélie and Reif, Marcus and Biegel, Ulrike and Unger, Lucia and Koch, Christoph},
  title = {A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17052}
}
Kostenlos starten →